Literature DB >> 1630812

Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene.

M Taniguchi1, T Iwamoto, I Nakashima, A Nakayama, M Ohbayashi, M Matsuyama, M Takahashi.   

Abstract

We established a cell line (designated Mel-ret) from a melanocytic tumor developed in a metallothionein/ret transgenic mouse. Unlike primary melanocytic tumors, which did not show malignant features, when the Mel-ret cells were transplanted into nude mice they invaded into surrounding tissues and had metastatic ability. Although the Ret proteins were expressed at similar levels in the cell line and the primary tumors, the level of tyrosine phosphorylation in the Mel-ret cells was much higher than that in the primary tumors. In particular, an 85-kDa tyrosine-phosphorylated band was specifically detected in the Mel-ret cells. These results suggest that the increase in tyrosine phosphorylation may be responsible for malignant transformation of the Mel-ret cells. Immunofluorescence and cell fractionation studies showed that the Ret proteins and most of tyrosine-phosphorylated proteins in the Mel-ret cells localized in the membrane fraction. No activation of phosphatidyl-inositol-3 kinase (PI-3 kinase), a target protein for several tyrosine kinases, was detected in the Mel-ret cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1630812

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Barium promotes anchorage-independent growth and invasion of human HaCaT keratinocytes via activation of c-SRC kinase.

Authors:  Nguyen Dinh Thang; Ichiro Yajima; Mayuko Y Kumasaka; Shoko Ohnuma; Takeshi Yanagishita; Rumiko Hayashi; Hossain U Shekhar; Daisuke Watanabe; Masashi Kato
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

2.  MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.

Authors:  Sabina Pozzi; Anna Scomparin; Dikla Ben-Shushan; Eilam Yeini; Paula Ofek; Alessio D Nahmad; Shelly Soffer; Ariel Ionescu; Antonella Ruggiero; Adi Barzel; Henry Brem; Thomas M Hyde; Iris Barshack; Sanju Sinha; Eytan Ruppin; Tomer Weiss; Asaf Madi; Eran Perlson; Inna Slutsky; Helena F Florindo; Ronit Satchi-Fainaro
Journal:  JCI Insight       Date:  2022-09-08

3.  Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.

Authors:  T Iwamoto; M Taniguchi; W Wajjwalku; I Nakashima; M Takahashi
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

4.  Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in E mu/ret transgenic mice.

Authors:  M Ichihara; T Iwamoto; K Isobe; M Takahashi; A Nakayama; M Pu; Y Dai; A Parashar; K Ohkus; M Kato
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.